BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38200427)

  • 1. Determinants of poor glycaemic control and proteinuria in patients with type 2 diabetes: a retrospective analysis of general practice records in Ireland.
    Sullivan M; O'Connor R; Hannigan A
    BMC Prim Care; 2024 Jan; 25(1):22. PubMed ID: 38200427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of periodontitis for glycaemic control in people with diabetes mellitus.
    Simpson TC; Clarkson JE; Worthington HV; MacDonald L; Weldon JC; Needleman I; Iheozor-Ejiofor Z; Wild SH; Qureshi A; Walker A; Patel VA; Boyers D; Twigg J
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD004714. PubMed ID: 35420698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
    Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription of psychotropic medication in patients with type two diabetes mellitus: A multi-practice study from Ireland.
    Keating P; O'Connor R; O'Doherty J; Hannigan A; Cullen W; Hickey L; Harnett A; Meagher D; O'Regan A
    Eur J Gen Pract; 2019 Jul; 25(3):157-163. PubMed ID: 31335225
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.
    Goudswaard AN; Stolk RP; Zuithoff P; Rutten GE
    Eur J Epidemiol; 2004; 19(6):541-5. PubMed ID: 15330126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic monitoring and control among high-risk patients with type 2 diabetes in Australian general practice during COVID-19.
    Barlow KJ; Fahey PP; Atlantis E
    Fam Med Community Health; 2023 Aug; 11(3):. PubMed ID: 37567729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Burden of Kidney Disease among Type 2 Diabetic Subjects Attending a Semi-Urban Tertiary Health Facility in South-West Nigeria.
    Ikem RT; Lawal-Bello AT; Soyoye DO; Fasanu AN; Kolawole BA
    West Afr J Med; 2023 Jun; 40(6):640-645. PubMed ID: 37390451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank.
    English AR; Prasad B; McGuigan DH; Horigan G; O'Kane M; Bjourson AJ; Shukla P; Kelly C; McClean PL
    Endocrinol Diabetes Metab; 2022 May; 5(3):e00326. PubMed ID: 35243827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control and its associated factors in type 2 diabetes patients at Felege Hiwot and Debre Markos Referral Hospitals.
    Shita NG; Iyasu AS
    Sci Rep; 2022 Jun; 12(1):9459. PubMed ID: 35676526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of poor glycaemic control amongst patients with diabetes followed at Vanga Evangelical Hospital, Democratic Republic of the Congo.
    Cedrick LM; Fina Lubaki JP; Francois LB; Gboyega OA; Philippe LN
    Afr J Prim Health Care Fam Med; 2021 Apr; 13(1):e1-e6. PubMed ID: 33970011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid dysfunction and glycaemic control among Type 2 diabetes mellitus patients in Ghana: A comparative cross-sectional study.
    Sakyi SA; Ameyaw B; Laing EF; Anthony R; Ephraim RKD; Effah A; Kwayie AA; Senu E; Anto EO; Acheampong E; Afranie BO; Amoani B; Opoku S
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e447. PubMed ID: 37621219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
    Heald A; Davies M; Stedman M; Livingston M; Lunt M; Fryer A; Gadsby R
    BMJ Open; 2019 Sep; 9(9):e028278. PubMed ID: 31494602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organisational and individual characteristics associated with glycaemic control among patients with type 2 diabetes: cross-sectional study in China.
    Wang H; Yao J; Yin X; Guo X; Yin J; Qu H; Sun Q
    BMJ Open; 2020 Apr; 10(4):e036331. PubMed ID: 32265251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.
    Mwita JC; Francis JM; Omech B; Botsile E; Oyewo A; Mokgwathi M; Molefe-Baikai OJ; Godman B; Tshikuka JG
    BMJ Open; 2019 Jul; 9(7):e026807. PubMed ID: 31340960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia and type 2 diabetes: implications from a retrospectively studied primary care case series.
    Chen CX; Li YC; Chan SL; Chan KH
    Hong Kong Med J; 2013 Jun; 19(3):214-21. PubMed ID: 23568938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal follow-up study of a type 2 diabetes "lost to follow-up" cohort - positive effect on glycaemic control after changes in medication.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Int J Circumpolar Health; 2020 Jan; 79(1):1773127. PubMed ID: 32498629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real-world study.
    Huang Y; Wang Y; Liu C; Zhou Y; Wang X; Cheng B; Kui C; Wang Y
    Diabetes Metab Res Rev; 2022 May; 38(4):e3514. PubMed ID: 34841643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.